Patented Medicines (Notice of Compliance) Regulations

Version of section 6 from 2008-06-12 to 2017-09-20:

  •  (1) A first person may, within 45 days after being served with a notice of allegation under paragraph 5(3)(a), apply to a court for an order prohibiting the Minister from issuing a notice of compliance until after the expiration of a patent that is the subject of the notice of allegation.

  • (2) The court shall make an order pursuant to subsection (1) in respect of a patent that is the subject of one or more allegations if it finds that none of those allegations is justified.

  • (3) The first person shall, within the 45 days referred to in subsection (1), serve the Minister with proof that an application referred to in that subsection has been made.

  • (4) Where the first person is not the owner of each patent that is the subject of an application referred to in subsection (1), the owner of each such patent shall be made a party to the application.

  • (5) Subject to subsection (5.1), in a proceeding in respect of an application under subsection (1), the court may, on the motion of a second person, dismiss the application in whole or in part

    • (a) in respect of those patents that are not eligible for inclusion on the register; or

    • (b) on the ground that it is redundant, scandalous, frivolous or vexatious or is otherwise an abuse of process in respect of one or more patents.

  • (5.1) In a proceeding in respect of an application under subsection (1), the court shall not dismiss an application in whole or in part solely on the basis that a patent on a patent list that was submitted before June 17, 2006 is not eligible for inclusion on the register.

  • (6) For the purposes of an application referred to in subsection (1), if a second person has made an allegation under subparagraph 5(1)(b)(iv) or (2)(b)(iv) in respect of a patent and the patent was granted for the medicinal ingredient when prepared or produced by the methods or processes of manufacture particularly described and claimed in the patent, or by their obvious chemical equivalents, it shall be considered that the drug proposed to be produced by the second person is, in the absence of proof to the contrary, prepared or produced by those methods or processes.

  • (7) On the motion of a first person, the court may, at any time during a proceeding,

    • (a) order a second person to produce any portion of the submission or supplement filed by the second person for a notice of compliance that is relevant to the disposition of the issues in the proceeding and may order that any change made to the portion during the proceeding be produced by the second person as it is made; and

    • (b) order the Minister to verify that any portion produced corresponds fully to the information in the submission or supplement.

  • (8) A document produced under subsection (7) shall be treated confidentially.

  • (9) In a proceeding in respect of an application under subsection (1), a court may make any order in respect of costs, including on a solicitor-and-client basis, in accordance with the rules of the court.

  • (10) In addition to any other matter that the court may take into account in making an order as to costs, it may consider the following factors:

    • (a) the diligence with which the parties have pursued the application;

    • (b) the inclusion on the certified patent list of a patent that should not have been included under section 4; and

    • (c) the failure of the first person to keep the patent list up to date in accordance with subsection 4(7).

  • SOR/98-166, ss. 5, 9
  • SOR/99-379, s. 3
  • SOR/2006-242, s. 3
  • err. (E), Vol. 140, No. 23
  • SOR/2008-211, s. 3
Date modified: